Skip to content
Home/Companies/MedTech/Bomedus

Bomedus

MedTech·Germany·Exited 2023·Held 8yr
Entry
2015
Hold
8yr
Exit
2023

Who owns Bomedus?

Bomedus was owned by NRW.BANK through NRW.Venture (2006 vintage) from 2015 to 2023.

Hand-verified · updated 2026-08-10

NRW.BANK
Investor
NRW.BANK
NRW.Venture · 2006 · VC

Key facts

HQGermany
SectorMedTech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2023

More from NRW.Venture

Other portfolio companies in the same fund.

JUPUS
Jupus
Active
LegalTechGermany· 2026
clockin
clockin
Active
SaaSGermany· 2025
Disco Pharmaceuticals
Active
BiotechGermany· 2025
eeden
Active
ClimateTechGermany· 2025
iDEL Therapeutics
Active
BiotechGermany· 2025
Lidrotec
Active
Deep TechGermany· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Bomedus

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Bomedus?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Bomedus.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue